Iranian researchers gave 81 type 2 diabetics broccoli sprout powder or placebo for four weeks.
Broccol sprout powder with a high sulforaphane concentration may significantly lower inflammation in type 2 diabetics, according to research out of Iran's Shahid Beheshti University of Medical Sciences.
Researchers assigned 81 subjects with type 2 diabetes to a daily dose of 10 g of broccoli sprout powder, 5 g of broccoli sprout powder, or placebo for four weeks. Changes in inflammation were assessed by measuring each subject's serum high-sensitive C reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis alpha at baseline and four weeks after treatment.
After four weeks, both doses of broccoli sprout powder significantly decreased CRP (20.5% and 16.3%) , IL-6 (3.6% and 0.7%), and TNF-alpha (1.6% and 10.9%). The findings are now published in the Journal of Functional Foods.